Xanthinol nicotinate

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE

COMPANY/UNDERTAKING

Supplier: KINFON PHARMACHEM CO.,LTD

F4, No.5 Torch Ave, JLP Dist, Chongqing 400080, China

website: www.echemix.com     email: sales@echemix.com

2. COMPOSITION/INFORMATION ON INGREDIENTS

Synonyms：             Xanthinol nicotinate

Formula:                C13H21N5O4.C6H5NO2

Molecular Weight:        434.45

CAS-No.:                437-74-1

3. HAZARDS IDENTIFICATION
Emergency Overview

OSHA Hazards

No known OSHA hazards

HMIS Classification

Health Hazard: 0

Flammability: 0

Physical hazards: 0

NFPA Rating

Health Hazard: 0

Fire: 0

Reactivity Hazard: 0

Potential Health Effects

Inhalation May be harmful if inhaled. May cause respiratory tract irritation.

Skin May be harmful if absorbed through skin. May cause skin irritation.

Eyes May cause eye irritation.

Ingestion May be harmful if swallowed.

4. FIRST AID MEASURES

If inhaled

If breathed in, move person into fresh air. If not breathing give artificial respiration

In case of skin contact

Wash off with soap and plenty of water.

In case of eye contact

Flush eyes with water as a precaution.

If swallowed

Never give anything by mouth to an unconscious person. Rinse mouth with water.

5. SPECIAL FIRE FIGHTING PROCEDURES
Flammable properties

Flash point no data available

Ignition temperature no data available

Suitable extinguishing media

Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

Special protective equipment for fire-fighters

Wear self contained breathing apparatus for fire fighting if necessary.

6. STEPS TO BE TAKEN IN CASE OF SPILL
Personal precautions

Avoid dust formation.

Environmental precautions

Do not let product enter drains.

Methods for cleaning up

Sweep up and shovel. Keep in suitable, closed containers for disposal.

7. HANDLING AND STORAGE
Handling   Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire

protection.

Storage   Keep container tightly closed in a dry and well-ventilated place.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Contains no substances with occupational exposure limit values.

Personal protective equipment

Respiratory protection

Respiratory protection is not required. Where protection from nuisance levels of dusts are desired, use type N95

(US) or type P1 (EN 143) dust masks. Use respirators and components tested and approved under appropriate

government standards such as NIOSH (US) or CEN (EU).

Hand protection   For prolonged or repeated contact use protective gloves.

Eye protection    Safety glasses

Hygiene measures   General industrial hygiene practice.

9. PHYSICAL AND CHEMICAL PROPERTIES

Appearance

Form solid

Safety data

pH no data available

Melting point no data available

Boiling point no data available

Flash point no data available

Ignition temperature no data available

Lower explosion limit no data available

Upper explosion limit no data available

Water solubility no data available

10. STABILITY AND REACTIVITY
Storage stability

Stable under recommended storage conditions.

Hazardous decomposition products

Hazardous decomposition products formed under fire conditions. – Carbon oxides, nitrogen oxides (NOx)

11. TOXICOLOGICAL INFORMATION
Acute toxicity

LD50 Oral – rat – 14,130 mg/kg

Irritation and corrosion

no data available

Sensitisation

no data available

Chronic exposure

IARC: No component of this product present at levels greater than or equal to 0.1% is identified as

probable, possible or confirmed human carcinogen by IARC.

ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as a

carcinogen or potential carcinogen by ACGIH.

NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a

known or anticipated carcinogen by NTP.

OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a

carcinogen or potential carcinogen by OSHA.

Developmental Toxicity – rat – Oral

Effects on Embryo or Fetus: Fetotoxicity (except death, e.g., stunted fetus). Effects on Newborn: Growth

statistics (e.g., reduced weight gain).

Developmental Toxicity – mouse – Oral

Effects on Embryo or Fetus: Fetotoxicity (except death, e.g., stunted fetus). Specific Developmental

Abnormalities: Musculoskeletal system.

Reproductive toxicity – rat – Subcutaneous

Effects on Newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4).

Reproductive toxicity – mouse – Oral

Effects on Fertility: Litter size (e.g.; # fetuses per litter; measured before birth). Effects on Newborn: Growth

statistics (e.g., reduced weight gain).

Signs and Symptoms of Exposure

Rash

Potential Health Effects

Inhalation May be harmful if inhaled. May cause respiratory tract irritation.

Skin May be harmful if absorbed through skin. May cause skin irritation.

Eyes May cause eye irritation.

Ingestion May be harmful if swallowed.

12. ECOLOGICAL INFORMATION
Elimination information (persistence and degradability)

no data available

Ecotoxicity effects

no data available

Further information on ecology

no data available

13. WASTE DISPOSAL CONSIDERATIONS
Product

Observe all federal, state, and local environmental regulations.

Contaminated packaging   Dispose of as unused product.

14. TRANSPORT INFORMATION
DOT (US)              IMDG                IATA

Not dangerous goods Not dangerous goods Not dangerous goods

15. OTHER INFORMATION ON REGULATION

OSHA Hazards

No known OSHA hazards

DSL Status

This product contains the following components that are not on the Canadian DSL nor NDSL lists.

Xantinol nicotinate CAS-No.: 437–74–1

SARA 302 Components

SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.

SARA 313 Components

SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the

threshold (De Minimis) reporting levels established by SARA Title III, Section 313.

SARA 311/312 Hazards

No SARA Hazards

Massachusetts Right To Know Components

No components are subject to the Massachusetts Right to Know Act.

Pennsylvania Right To Know Components

Xantinol nicotinate CAS-No.: 437–74–1

New Jersey Right To Know Components

Xantinol nicotinate CAS-No.: 437–74–1

California Prop. 65 Components

This product does not contain any chemicals known to State of California to cause cancer, birth, or any other

reproductive defects.

This MSDS is correct to the best of our knowledge and belief at the date of its publication but we

cannot accept liability for any loss, injury or damage which may result from its use.